Endo Trust's $4.1B Claim Against TPG Survives Dismissal Bid
TPG Capital must face a lawsuit seeking to claw back $4.1 billion it made from the sale of a generic opioid manufacturer to Endo International PLC, whose trustee has alleged it...To view the full article, register now.
Already a subscriber? Click here to view full article